We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
The three major U.S. stock indexes opened higher this morning following a better-than-expected PMI reading from China (more coverage here) that was mostly untempered by lower-than-expected PMI readings from Europe (more coverage…
The three major U.S. stock indexes opened lower this morning and remained in negative territory all day. The decline is down to weak earnings from many U.S. firms reporting results today. In…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Tuesday. AMC Networks Inc. (NASDAQ: AMCX) cut to Neutral at JPMorgan. Amgen Inc.…
If the brand of Lance Armstrong was a stock, let’s just be nice say that the value would have tanked. The reality is that the exchange would have probably halted trading if…
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from…
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement…
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short…
While many individual Americans are struggling financially, some of the largest corporations in the United States are sitting on billions in cash. Moody’s pointed out in March that U.S. nonfinancial companies’ cash holdings rose to…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday. Amgen Inc. (NASDAQ: AMGN) cut to Neutral at R.W. Baird. Automatic Data…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Advanced Micro Devices Inc. (NYSE: AMD) raised to Neutral from Sell at…
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short…
It was just on Monday that we released the 24/7 Wall St. “12 Big Dividend Hikes Coming Before The End of 2012” and we already have one of the twelve coming true. …
Most investors have discovered that earning less than 1% per year in short-term Treasuries or even less than 2% out in the 10-year Treasury is no fun. Longer-dated Treasury bonds also are proving…
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the…
